Delivery Order SPE2DB20D1004-SPE2DB25FNKDM

The Defense Logistics Agency awarded a $5,162.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of delivery orders with DLA covering a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains.

This delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, PA and reflects the company's role as a key supplier within DLA's Medical Supply Chain. The TYPHIM VI vaccine product supports military readiness and healthcare requirements. As a child contract under the larger SPE2DX vehicle, this order demonstrates the flexibility and scalability of AmerisourceBergen's relationship with DLA in fulfilling diverse federal medical supply needs. The firm fixed-price structure ensures cost predictability for the government while the competitive award process validates the contractor's capability to meet federal procurement standards in the pharmaceutical supply sector.